A study published in Stem Cells International investigates the clinical outcomes of combining autologous adipose-derived mesenchymal stem cells (AD-MSCs) with high tibial osteotomy for treating knee osteoarthritis.
September, 04 2024
A study published in Stem Cells International investigates the clinical outcomes of combining autologous adipose-derived mesenchymal stem cells (AD-MSCs) with high tibial osteotomy for treating knee osteoarthritis. The research reveals that the therapeutic efficacy is closely linked to the stemness and senescence of the MSCs, offering insights into optimizing regenerative treatments for joint disorders.
A study published in Stem Cells International investigates the clinical outcomes of combining autologous adipose-derived mesenchymal stem cells (AD-MSCs) with high tibial osteotomy for treating knee osteoarthritis. The research reveals that the therapeutic efficacy is closely linked to the stemness and senescence of the MSCs, offering insights into optimizing regenerative treatments for joint disorders.
Latest news
Stem cells: restoring the liver according to science
January, 16 2025
Exosoms: helping blood vessels after treatment
January, 01 2025
Exosomes on the lookout for lung disease
November, 19 2024
Stem cells and exosomes against DIC syndrome
November, 16 2024
How do stem cells help fight kidney aging?
September, 21 2024